DEL MAR, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- American Diversified Holdings Corporation (ADHC) is a publicly traded company trading on the Over the Counter Market under the ticker symbol “ADHC”. The company is currently trading under the PINK-Current status. Currently the company has two operating divisions: American Cannabis Holdings Inc. and Brazos Biomedical, Inc. Profiles of both divisions can be found below.

The Management has been working diligently with our partners to setup up solid operating business with strong potential for enhancing shareholder value.

OTC-QB Up-listing; ADHC has met with our SEC counsel and SEC Auditors and has received proposals to provide the necessary audits and legal filings to up-list to the OTC-QB. Management believes that trading on the OTC-QB will provide significant advantages to building shareholder value by attracting more institutional investors, providing more transparency to the market and creating a more appealing investment opportunity for raising capital and broadening our shareholder base. 

In addition to our infused beverage business, ADHC management is meeting with Cannabis growers, suppliers, technology providers and other Cannabis business sector. We are targeting growing operations as acquisition candidates particularly in Canada where there are no government restrictions.

The first step for ADHC is to develop a distribution model to provide CBD Infused beverages to the US consumer markets primarily through ecommerce technology. US Federal Regulations are rapidly evolving in the Cannabis arena. With the Canadian legalization and legalization in many large US states, there will be tremendous motivation for the US congress to fully legalize Cannabis. Analysts have estimated the legal Cannabis business could well exceed $50 billion in the US alone. When this occurs American Diversified Holdings Corporation “ADHC” with be very well positioned to capitalize on the billions of dollars of business in the legal cannabis industry.

Several Major developments have occurred that have provided the impetus for ADHC to make the move into Cannabis.

  • Canada fully legalized Cannabis nationwide on October 17th, 2018
  • US Federal policy has loosened is classification of CDB to a schedule 5 drug. CBD in the non-psycho-active component of the cannabis plant.
  • Numerous pharmaceutical companies are researching CBD to develop therapies for major diseases and disorders.
  • Constellation Brands (maker of Corona and Modela beer) has invested $4 billion into Constellation Brands a Canadian Cannabis grower.
  • Coca Cola (KO) is in talks to enter the Aurora Cannabis (ACBFF) to develop CBD infused drinks
  • Cowen Analyst Vivien Azer estimated the Cannabis market could grow to over $200 billion in the next 15 years.
    In addition to our infused beverage business, ADHC management is meeting with Cannabis growers, suppliers, technology providers and other Cannabis business sector.

AMERICAN CANNABIS HOLDINGS Inc. (An Operating Division of “ADHC”) American Cannabis Holdings Inc. has entered into a supply and distribution agreement with a manufacturer of CBC infused Tea. The company in the process of development an ecommerce site where consumers can purchase the CBD infused tea for direct shipment. Each cup of tea will contain 5 mg of CBD and will be sold in 18 unit packages at very competitive prices.

The tea comes in three flavors: CBD Chamomile Blend, CBD Matcha Green Tea, CBD Peppermint, and CBD Turmeric and Ginger Tea. These teas are crafted using nano-sized particle of WATER-SOLUBLE CBD, the innovative process ensures the CBD actually ends up in the tea and can be extracted into the hot water unlike Oil soluble CBD. ACHI will be embarking on several strategies to develop this business using ecommerce, On-line sales, Business to Business, Business to Consumer models leveraging marketing partners, retailers, product promotion services. It is anticipated that ACHI will be offering CBD infused teas for sale to consumers in the next few weeks.

Major companies in the Cannabis space include:
LEVEL BRANDS INC (LEVB), NEW AGE BEVERAGE CORP (NBEV), TILRAY (TLRY), CANOPY GROWTH CORP (CGC), CRONOS GROUP INC. (CRON), AURORA CANNABIS (ACBFF), CLS HOLDINGS (CLSH), ALEAFIA HEALTH INC. (ALEAF), CONSTELLATION BRANDS (TICKER), INDIAN GLOBALIZATION CAPITAL INC. (IGC), CHINESE INVESTORS.COM (CIIX), PURATION INC. (PURA).

BRAZOS BIOMEDICAL LLC is a bio device company utilizing electro stimulation for pain management to improve patient outcomes through creative innovation with a core competency in the migraine and headache pain space. Our Patented Flagship: product AURACIStm is a “TENS” Headband device worn by migraine suffers to alleviate the pain from chronic migraines. “TENS” or Transcutaneous Electric Nerve Stimulation is a technology that uses electric impulse to block nerve pain. The founder of AURACIStm developed AURACIStm as the result of performing the OMEGA surgical procedure for more severe patients. There are 38 million potential patients in the US resulting $58 billion market. Management is currently meeting with medical device developers, FDA consultants and major distribution partners. See www.brazosbio.com for more information.

ADHC is a holding company that provides executive management, corporate governance, administrative support, financial advice, and introductions to capital sources to various micro-cap private and public companies that have proven revenues and business models.

This press release contains forward-looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the Company's plans to change and are in no way intended to guarantee that the Company will be successful in executing its plans. common stock currently trades on the over-the-counter under the symbol ADHC. This press release in no way constitutes any recommendation regarding the securities of ADHC or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of ADHC, and no reference has been made that this release contains all information.

Contact: adhcinvestor@gmail.com Tel: 858-259-4534